Medical network, June 6, on June 1, China biotechnology development center issued "on the national key research and development plan" stem cells and translational research "and so on five key special 2017 project arrangement of the public notice. 

 

The notice will "stem cells and translational research", "digital medical equipment research and development", "major chronic noncommunicable diseases prevention and control research", "biomedical materials research and development and tissue repair alternative" and "biological security key technology research and development" focus on special 2017 project project information to the public. In addition, the amount of funds that each project will receive from the central government will also appear in the annex. 

 

In 36 mainly dominated by medical device companies, a total of 32 enterprises involved, the central government will support 546.64 million yuan, including Shanghai united shadow medical technology co., LTD occupies four, will receive 68.74 million yuan, for a single supported amount of most enterprises. 

 

Second, neusoft is a total of 2 companies -- shenyang neusoft city kang medical system co., LTD., shenyang neusoft medical systems co., LTD. Three projects to be included in the support will be given to 51.2 million yuan. 

 

The company of weigao group co., LTD., chongqing kingsoft technology (group) co., LTD., has one project selected, which will support 43,070 and 42710 respectively. 

In addition, there will be 30 digital and clinical equipment research and development projects, including 25 universities and hospitals, which will also be supported, involving 238.93 million, as follows: